10-125795004-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000375.3(UROS):c.562-26C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.447 in 1,589,188 control chromosomes in the GnomAD database, including 161,003 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.43 ( 14234 hom., cov: 32)
Exomes 𝑓: 0.45 ( 146769 hom. )
Consequence
UROS
NM_000375.3 intron
NM_000375.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.352
Genes affected
UROS (HGNC:12592): (uroporphyrinogen III synthase) The protein encoded by this gene catalyzes the fourth step of porphyrin biosynthesis in the heme biosynthetic pathway. Defects in this gene cause congenital erythropoietic porphyria (Gunther's disease). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-125795004-G-A is Benign according to our data. Variant chr10-125795004-G-A is described in ClinVar as [Benign]. Clinvar id is 1266364.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.459 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UROS | NM_000375.3 | c.562-26C>T | intron_variant | Intron 8 of 9 | ENST00000368797.10 | NP_000366.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.429 AC: 65234AN: 151958Hom.: 14220 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
65234
AN:
151958
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.400 AC: 100478AN: 250906 AF XY: 0.407 show subpopulations
GnomAD2 exomes
AF:
AC:
100478
AN:
250906
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.449 AC: 644791AN: 1437112Hom.: 146769 Cov.: 27 AF XY: 0.448 AC XY: 321367AN XY: 716656 show subpopulations
GnomAD4 exome
AF:
AC:
644791
AN:
1437112
Hom.:
Cov.:
27
AF XY:
AC XY:
321367
AN XY:
716656
Gnomad4 AFR exome
AF:
AC:
13996
AN:
32916
Gnomad4 AMR exome
AF:
AC:
11073
AN:
44668
Gnomad4 ASJ exome
AF:
AC:
9920
AN:
25974
Gnomad4 EAS exome
AF:
AC:
12669
AN:
39516
Gnomad4 SAS exome
AF:
AC:
36297
AN:
85702
Gnomad4 FIN exome
AF:
AC:
22677
AN:
53338
Gnomad4 NFE exome
AF:
AC:
510711
AN:
1089674
Gnomad4 Remaining exome
AF:
AC:
25572
AN:
59612
Heterozygous variant carriers
0
16697
33393
50090
66786
83483
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
14914
29828
44742
59656
74570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.429 AC: 65279AN: 152076Hom.: 14234 Cov.: 32 AF XY: 0.423 AC XY: 31479AN XY: 74340 show subpopulations
GnomAD4 genome
AF:
AC:
65279
AN:
152076
Hom.:
Cov.:
32
AF XY:
AC XY:
31479
AN XY:
74340
Gnomad4 AFR
AF:
AC:
0.42852
AN:
0.42852
Gnomad4 AMR
AF:
AC:
0.33246
AN:
0.33246
Gnomad4 ASJ
AF:
AC:
0.381912
AN:
0.381912
Gnomad4 EAS
AF:
AC:
0.300775
AN:
0.300775
Gnomad4 SAS
AF:
AC:
0.424179
AN:
0.424179
Gnomad4 FIN
AF:
AC:
0.428869
AN:
0.428869
Gnomad4 NFE
AF:
AC:
0.463186
AN:
0.463186
Gnomad4 OTH
AF:
AC:
0.42654
AN:
0.42654
Heterozygous variant carriers
0
1881
3761
5642
7522
9403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
606
1212
1818
2424
3030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1297
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cutaneous porphyria Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at